Stockreport

LogicBio Therapeutics Provides Update on FDA Review of Investigational New Drug Application for LB-001 for Methylmalonic Acidemia

ContextLogic Inc. - Class A  (LOGC) 
Last contextlogic inc. - class a earnings: 8/13 08:00 am Check Earnings Report
PDF CAMBRIDGE, Mass., Feb. 10, 2020 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably trea [Read more]